The June issue of the Journal of Drugs in Dermatology focuses on the topics of acne and rosacea, and features additional articles on topics such as atopic dermatitis and psoriasis. Straight from the JDD Editor’s desk, we share this month’s issue highlights:
Guest Editor James Q. Del Rosso discusses roadblocks that impede patient ability to obtain medications selected by their dermatologists in The Hypocrisy of Many Pharmacy Benefit Managers: “Pay No Attention to That Man Behind the Curtain”
Acne causes and effective treatments are often poorly understood by the public, even those who have acne themselves in Concerns, Expectations, and Management Gaps Relating to Acne and Associated Scarring Identified from Survey Data
Tazarotene 0.045% Lotion for Moderate-to-Severe Acne Patients: Pooled Phase 3 Analysis by Age and Sex demonstrated safety and efficacy in females and males with moderate-to-severe acne across all age groups.
Further efforts are needed to improve the visibility and viewer experience of accurate content on social media in Vitiligo Health Education: A Study of Accuracy and Engagement of Online Educational Materials
The vehicle into which a topical medication is placed can either improve or damage the skin barrier in Vehicle Effects on the Rosacea Skin Barrier
Efficacy for truncal acne was observed within 3 weeks after treatment in Management of Truncal Acne With Oral Sarecycline: Pooled Results from Two Phase-3 Clinical Trials
The use of these standardized outcome measures would help guide treatment selection in Parametric Acne Severity (PAS) Score and Lesion Counts from Multi-Modality Facial Image Analysis Correlates Strongly With Investigator Assessment
FDA guidance may be too conservative in Acne Vulgaris: The Majority of Patients Do Not Achieve Success According to FDA Guidance
Greater management guidance and more comprehensive discussions may be required in Analysis of Reddit Reveals Atopic Dermatitis Patient Questions.
A 14-week trial was designed for Evaluation of a First-in-Class Proteasome Inhibitor in Patients With Moderate to Severe Rosacea
Psychosocial therapies are an important part of treating vitiligo patients and should be discussed with patients during their office visits in A Multi-Centered Case-Control Study of Vitiligo Support Groups and Quality of Life
Botulinum Neurotoxin Type A as an Adjuvant to Reduce Scarring After Dermatological Surgery may be associated with more rapid post-procedural healing and less visible scarring
The effects of deep dermal to immediate sub-dermal micropuncture injections were evaluated in Cell-Free Blood Cell Secretome (BCS) Counteracts Skin Aging and Restores Firmness and Elasticity
Hair care products should be considered as a possible contributor to acne in Efficacy of a Non-Comedogenic Hair Care Regimen for the Reduction of Mild-to-Moderate Truncal and Facial Acne: A Single-Arm 8-Week Study
Revisiting the Skin Health and Beauty Pyramid: A Clinically Based Guide to Selecting Topical Skincare Products includes newer introductions since 2014 to present the physician, skin care professionals, and patients with a current organized hierarchical approach to healthy skin.
Authors explore safety and efficacy of a novel modality in Seeing the Treatment of Psoriasis in a New Light: A Novel Medical Device Utilizing Localized Coal Tar and Narrowband UVB for Targeted Treatment of Plaque Psoriasis
Did you enjoy this JDD Highlights article? Find more here.